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Abstract
Although the importance of patient participation in the design and evaluation of health programs and services is 
well-documented, there is scarcity of research with regard to patient association (PA) participation in health policy 
decision-making processes. To this end, the present study aimed to validate further a previously developed instrument 
as well as to investigate the degree of PA participation in health policy decision-making in Cyprus. A convenient 
sample of 114 patients-members of patients associations took part in the study. Participants were recruited from 
an umbrella organization, the Pancyprian Federation of Patient Associations and Friends (PFPA). PA participation 
in health policy decision-making was assessed with the Health Democracy Index (HDI), an original 8-item tool. 
To explore its psychometric properties, Cronbach α was computed as regards to its internal consistency, while its 
convergent validity was tested against a self-rated question enquiring about the degree of PA participation in health 
policy decision-making. The findings revealed that the HDI has good internal consistency and convergent validity. 
Furthermore, PAs were found to participate more in consultations in health-related organizations and the Ministry 
of Health (MoH) as well as in reforms or crucial decisions in health policy. Lower levels were documented with 
regard to participation in hospital boards, ethics committees in clinical trials and health technology assessment 
(HTA) procedures. Overall, PA participation levels were found to be lower than the mid-point of the scale. Targeted 
interventions aiming to facilitate patients’ involvement in health policy decision-making processes and to increase its 
impact are greatly needed in Cyprus.
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Introduction
Patient involvement is critical in health and healthcare. It has 
been shown that patient dissatisfaction is strongly linked to 
lack of information and poor knowledge of clinical shared-
decision-making.1 Patients should collaborate with their 
physician to better understand aspects of their disease, so 
as to actively participate in treatment decisions and provide 
their informed consent to any treatment plan.2,3 In recent 
years, a number of initiatives and interventions have been 
implemented worldwide in order to encourage and support 
patients to take a more active role in protecting their health.4 
These interventions have focused on fostering patient 
empowerment, enhancing health literacy and supporting self-
management in chronic health conditions.5-7 Well-informed 
and active patients may facilitate decision-making about 
treatment, contribute to reduced likelihood for medical errors 
and are in low risk for relapse and poor health outcomes.6-8
Concomitantly, research evidence suggests that patient 
participation is a fundamental component for designing 
effective and sustainable healthcare systems.9,10 Researchers 
advocate patients involvement in health policy decision-
making as equal partners in order to ensure that population 
health needs are incorporated in the policy agenda, as well 
as that the services delivered and policies implemented are 
addressing these needs effectively.11-13 Increased patient 
involvement is associated with improved quality and safety 
of healthcare services, higher cost-effectiveness and better 
health outcomes.12,14 In this reasoning, patient involvement 
is indispensable in the development and implementation of 
health policies.13,15,16
In this context, many governmental and non-governmental 
organizations across Europe have carried out campaigns 
aiming to raise patient awareness with regard to participating 
in health policy decision-making.16 Moreover, relevant laws 
and regulations, mostly at local or federal levels, have been 
formulated in most European countries in order to facilitate 
patients’ interaction with health authorities and thus to 
contribute effectively in health policy decision-making.15,17-20 
Evidence has indicated that although efforts aimed to 
improve patient participation have been intensified, only few 
of these initiatives have been evaluated.21 As a result of this, 
a lot of resources are spent without the anticipated impact. 
Assessing patient involvement in different stages of health 
policy decision-making processes could shed light on barriers 
preventing individuals from having a more active role in the 
development of programs and policies impacting on their 
health.4,22 Furthermore, it may guide future interventions 
geared towards targeting these obstacles and, thus, upgrade 
the role of patients as equal partners.7,17
According to researchers and health policy-makers the 
position of patients can be bolstered if they are grouped 
together.23 In this reasoning, patient associations (PAs) can be 
indispensable in facilitating democracy, promoting patients’ 
interests, and influencing health policies.24 Nonetheless, 
Souliotis et al
International Journal of Health Policy and Management, 2016, 5(8), 461–466462
research on their role in impacting policy decision-making 
processes is scarce and it is largely based on qualitative 
methods.25-27 In an endeavour to fill this gap, a brief tool for 
measuring PA participation in health policy decision-making 
processes was developed and validated in a random sample of 
members of PAs in Greece.28 In particular, the development 
of the index followed the steps of defining and reviewing 
the construct, item drafting and reviewing as well as pilot 
testing of its psychometric properties (reliability: internal 
consistency, test-retest reliability and validity: construct 
validity and convergent validity). Evidence indicated that the 
tool has good psychometric properties.28
In this context, the present study aimed to validate further 
the particular index as well as to explore the degree of PAs 
participation in health policy decision-making in Cyprus. 
Methods
Sample and Procedure
A convenient sample of 114 patients – members of PAs 
(22 men and 92 women) participated in the present study. 
Participants were recruited from the umbrella patient 
organization “Pancyprian Federation of Patient Associations 
and Friends” (PFPA), the national coalition of PAs in the 
country. The PFPA consists of several PAs, which cover a 
diversity of chronic health conditions, while there are certain 
PAs which are not disease-specific. Therefore, to be eligible 
for participation, patients had to be members of a PA of the 
PFPA, to be fluent in Greek language and to be older than 18 
years old. 
All members of the PFPA were invited to participate in 
the study. Initial recruitment was carried out via email. An 
invitation for participation was sent to all PAs that belonged 
to the PFPA and each PA forwarded the email invitation to its 
members. An online, self-reported questionnaire was used for 
data collection. Once an individual had agreed to participate 
and signed the written informed consent, the board members 
of the PFPA forwarded the web-link accordingly. The web-
page did not ask for participants’ personal information and as 
a result of this, their anonymity were ensured. 
Instrument
The questionnaire was comprised of two parts, a socio-
demographic section and the Health Democracy Index 
(HDI).28 The HDI is an original scale consisting of 8 items, 
enquiring about PAs’ participation in health policy decision 
processes at the organizational design and governance level 
as well as at the policy-making level29: reforms, panels at the 
MoH, panels in other prominent health-related organizations, 
hospital boards, ethics committees in clinical trials, health 
technology assessment (HTA) procedures and the national 
parliament. For each item, 7 response options were provided: 
(i) it is not a legal requirement and it never happens, (ii) it 
is not a legal requirement and it rarely happens, (iii) it is 
not a legal requirement but it often happens, (iv) it is a legal 
requirement and it never happens, (v) it is a legal requirement 
and it often happens, (vi) it is a legal requirement and it 
happens very often, and (vii) it is a legal requirement and it 
always happens. In addition, there is one question enquiring 
about the frequency whereby a substantial change in a health 
policy decision was evoked as a result of PA’s involvement in 
the process. For this item, ratings were made on a 7-point 
scale reflecting a frequency dimension: never – very rarely 
– rarely – sometimes – often – very often. Consistent with 
these, higher composite scores indicate higher degree of PA 
participation in health policy decision-making processes. 
As already stated, for the development of the index, the 
subsequent steps were followed: (i) definition of the construct, 
(ii) review of the construct definition, (iii) item drafting, (iv) 
item review, (v) pilot testing of its psychometric properties 
(reliability: internal consistency, test-retest reliability and 
validity: construct validity and convergent validity). In 
particular, after the construct PAs participation in health 
policy processes was defined, its definition was reviewed by a 
panel of 34 stakeholders in the field: patients-members of PAs 
(n = 10), representatives of PAs (n = 10), health policy-makers 
(n = 5) , healthcare providers (n = 5) and researchers (n = 5). 
The panel was selected on the grounds of their knowledge 
and experience on the topic and, thus, purposive sampling 
was employed.
Item drafting occurred after drawing up a list of potential 
items on the grounds of existing international literature. 
Furthermore, a focus group of 12 patients-members of PAs 
was also conducted. Patients involved in the activities of PAs 
were invited to take part in a focus group centred on aspects 
of PA participation in health policy processes. This process 
resulted in the inclusion of 10 items in the scale. The panel 
of experts who reviewed the definition of the construct 
was further invited to review and comment on the derived 
items. As a result of this, the 10 items were reduced into 8. 
Moreover, the panel commented on the need to weight items, 
as participation in these different facets of health policy were 
not of equal importance. By adopting a Delphi methodology 
weights were assigned to each item of the index. In this 
rationale, the construct and face validity of the HDI was 
substantiated to some extent. 
Moreover, in a random sample of 414 patients-members of 
PAs in Greece, the psychometric properties of the index were 
examined. The index displayed high internal consistency 
(Cronbach α = 0.851) and test-retest reliability (rho = 0.873). 
Exploratory factor analysis revealed that the construct is 
unidimensional; while confirmatory factor analysis indicated 
an adequate fit of the one-factor model (root mean square 
error of approximation [RMSEA] = 0.079, comparative fit 
index [CFI] = 0.976 and goodness-of-fit [GFI] = 0.972). As 
regards convergent validity, the HDI composite score was 
found to be highly and positively correlated with one question 
tapping self-rated degree of PA participation in health policy 
processes (rho = 0.734, P < .0001).28
Congruent with the pilot study in Greece, the questionnaire 
of the present study also included one question asking 
participants to rate their PA’s degree of participation in health 
policy decision processes. Ratings on the particular item were 
made on a 6-point scale ranging from absent to very high. The 
question was incorporated in order to explore the convergent 
validity of HDI, as there is no other scale to measure PA 
participation in health policy decision-making.2
Statistical Analysis 
Continuous variables are presented with mean and standard 
deviation (SD) or with median and interquartile range (IQR). 
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Qualitative variables are presented with absolute and relative 
frequencies. The internal consistency of the questionnaire 
was analyzed with Cronbach’s α. Reliability equal to or greater 
than 0.70 was considered acceptable. An exploratory factor 
analysis was used in order to evaluate construct validity of 
the questionnaire and to determine whether the scale could 
be considered as a measure of a single construct. Principal 
component analysis (PCA) was chosen as extraction method 
using varimax rotation. The cut-off point for factor loadings 
was 0.40 and for eigenvalues it was 1.00. Spearman correlation 
coefficients were computed to explore the intercorrelations 
of the HDI items and their association with the degree of 
participation of their organization in health policy decision-
making . It was supposed that the aforementioned correlations 
would be significant and would further confirm the validity 
of the index. Correlation coefficient between 0.10 and 0.30 
are considered low, between 0.31 and 0.50 moderate and 
over 0.50 high. P values reported are two-tailed. Statistical 
significant level was set at .05 and analysis was conducted 
using SPSS 19.0.
Results
Sample Characteristics
Sample consisted of 114 participants (22 men and 92 
women) with mean age 44.5 years (SD = 12.34 years). Sample 
characteristics are presented in Table 1. Most of the subjects 
were Cypriot (76.32%), while 15.79% were Greek. Seventy-two 
percent had high educational level and most of participants 
were married (64.03%). The mean duration of disease was 
10.72 years (SD = 10.00 years).
Psychometric Properties of the Index (Reliability, Construct 
Validity, and Convergent Validity)
Table 2 presents intercorrelations of the HDI items. All items 
were highly and positively correlated. The highest correlation 
was found between the questions “Does your patient 
organization take part in boards of hospitals?” and “Does 
your patient organization take part in Ethics Committees for 
clinical trials” and between “Does your patient organization 
take part in HTA procedures?” and “Does your patient 
organization take part in Ethics Committees for clinical 
trials.” Additionally, very high was the correlation between the 
question “Does your patient organization take part in reforms 
or crucial decisions in health policy?” and the questions “Does 
your patient organization take part in workshops or panels 
held at the MoH?” and “Does your patient organization take 
part in workshops or panels in other important organizations, 
pertinent to health?”
A PCA with a varimax rotation was conducted. In the final 
model all items were entered into the factor analysis and 
one factor was revealed with eigenvalue more than one that 
accounted for 68% of the total variance. Factor loadings 
ranged from 0.75 to 0.87. Internal consistency reliability for 
the HDI was accepted with Cronbach’s alpha equal to 0.91.
Table 3 shows correlation coefficients of the HDI items with 
the self-rated degree of PA participation in health policy 
decision-making (convergent validity). All HDI items were 
positively and significantly correlated with the particular 
question. The highest correlations were found with the items 
“Does your patient organization take part in reforms or crucial 
Table 1. Sample Characteristics
n (%)
Age, mean (SD) 44.5 (12.34)
Gender
 Men 22 (19.30)
 Women 92 (80.70)
Marital status
 Married/civil partnership 73 (64.03)
 Co-habiting 5 (4.38)
 Widowed 3 (2.63)
 Divorced 5 (4.38)
 Single/non co-habiting partner 28 (24.58)
Nationality
 Cypriot 87 (76.32)
 Greek 18 (15.79)
 Both 9 (7.89)
Educational level
 None 1 (0.88)
 Secondary school education 20 (17.54)
 Vocational qualification 11 (9.65)
 Higher diploma or degree 50 (43.86)
 Postgraduate degree 32 (28.07)
Duration of disease, mean (SD) 10.72 (10.00)
Position in the organization
Participant 18 (18.37)
Non-voting active member 30 (30.61)
Voting member 26 (26.53)
President or other board member 24 (24.49)
Years of membership, mean (SD) 6.47 (5.81)
Abbreviation: SD, standard deviation.
decisions in health policy?,” “How often do you observe a 
substantial change in the content of a health policy decision 
as a result of interference from a patient organization? (yours 
or another’s)” and “Does your patient organization take part 
in workshops or panels held at the MoH?” Similarly, a strong 
and positive correlation was also found between the particular 
question and the scale score (r = 0.815, P < .001)
Degree of Patient Associations Participation in Health Policy 
Decision-Making 
Summary statistics for the HDI items are shown in Table 
4. The lower median value was 1 and was found for the 
questions “Does your patient organization take part in boards 
of hospitals?,” “Does your patient organization take part in 
Ethics Committees for clinical trials?” and “Does your patient 
organization take part in HTA procedures?” while the highest 
median value was 4 and it was found for the question “Does 
your patient organization take part in workshops or panels in 
other important organizations, pertinent to health?”
Discussion
The present study builds upon previous work, conducted on 
a random sample of patients with chronic illnesses-members 
of PAs in Greece.28 In particular, a self-reported instrument 
to evaluate the degree of PA participation in various facets of 
health policy from patients’ perspective (HDI) was developed 
and validated. In the present study, the psychometric properties 
of the index were further substantiated by demonstrating 
good internal consistency and good convergent validity in a 
convenient sample of patients-members of PAs in Cyprus. 
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Moreover, the present study revealed that the higher 
participation levels were documented with regard to PA 
participation in workshops or panels in important health-
related organizations, in the MoH and in reforms or crucial 
decisions in health policy. Lower degree was documented with 
respect to participation in hospital boards, Ethics committees 
for clinical trials and HTA procedures. Moreover, the HDI 
composite score was below the mid-point (median = 20, 
mid-point = 28). Consistent with this, PAs do not participate 
substantially in health policy decision-making in Cyprus. 
A possible explanation for this finding is that PAs may lack 
the necessary resources, tools or skills that would enable them 
to participate in decision-making processes, while advocating 
effectively the health needs of their members. This is in line 
with previous studies, suggesting that targeted interventions 
to support patient organizations in advocacy strategies are 
necessary to improve the impact of patient participation in 
health policies.30,31 As a response to this requirement, many 
countries have adopted a “bottom-up” approach as a capacity 
building strategy in order to facilitate the involvement of 
patient groups in health decision-making.16,21 In several 
European countries, in conjunction with federal and regional 
health councils and targeted interventions, participatory 
decision-making processes have been integrated in law 
formulation, so as to facilitate patient groups to freely express 
their opinion and to participate equally in health policy 
decision-making.2,8,16,20,21,31
Results of the present study should be interpreted in light 
Table 2. Intercorrelations of the HDI items
Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8
Does your patient organization take part in reforms or crucial decisions in health 
policy?
0.83 0.80 0.58 0.63 0.64 0.63 0.64
Does your patient organization take part in workshops or panels held at the MoH? 0.79 0.67 0.65 0.65 0.68 0.62
Does your patient organization take part in workshops or panels in other 
important organizations, pertinent to health?
0.60 0.60 0.60 0.60 0.62 0.65
Does your patient organization take part in boards of hospitals? 0.90 0.84 0.70 0.60
Does your patient organization take part in Ethics Committees for clinical trials? 0.88 0.70 0.62
Does your patient organization take part in HTA procedures? 0.72 0.67
Does your patient organization take part in the national parliament during 
decision-making for important health policies/issues?
0.77
Abbreviations: HDI, Health Democracy Index; MoH, Ministry of Health; HTA, health technology assessment.
Note: all correlations were significant at P < .001.
Table 3. Correlation Coefficients of the HDI Items and Total Score With the Self-rated Degree of PA Participation in Health Policy Decision-Making
Degree of Participation of Their Organization 
in Health Policy Decision-Making
Does your patient organization take part in reforms or crucial decisions in health policy? 0.81
Does your patient organization take part in workshops or panels held at the MoH? 0.71
Does your patient organization take part in workshops or panels in other important organizations, pertinent 
to health?
0.66
Does your patient organization take part in boards of hospitals? 0.50
Does your patient organization take part in Ethics Committees for clinical trials? 0.52
Does your patient organization take part in HTA procedures? 0.54
Does your patient organization take part in the national parliament during decision-making for important 
health policies/issues?
0.67
How often do you observe a substantial change in the content of a health policy decision as a result of 
interference from a patient organization? (yours or another’s)
0.72
HDI total score 0.81
Abbreviations: HDI, Health Democracy Index; MoH, Ministry of Health; PA, patient association; HTA, health technology assessment.
Note: all correlations were significant at P < .001.
Table 4. Summary Statistics for the HDI Items
Mean (SD) Median (IQR)
Does your patient organization take part in reforms or crucial decisions in health policy? 3.54 (1.61) 3.53 (2-5)
Does your patient organization take part in workshops or panels held at the MoH? 3.31 (1.72) 3 (2-5)
Does your patient organization take part in workshops or panels in other important organizations, pertinent to health? 3.71 (1.61) 4 (2-5)
Does your patient organization take part in boards of hospitals? 2.10 (1.59) 1 (1-3)
Does your patient organization take part in Ethics Committees for clinical trials? 2.10 (1.59) 1 (1-2)
Does your patient organization take part in HTA procedures? 2.24 (1.63) 1 (1-3)
Does your patient organization take part in the national parliament during decision-making for important health 
policies/issues?
2.70 (1.64) 2 (1-4)
How often do you observe a substantial change in the content of a health policy decision as a result of interference from 
a patient organization? (yours or another’s)
3.33 (1.44) 3 (2-4)
HDI total score 23.04 (10.00) 20.00 (15.00-29.00)
Abbreviations: HDI, Health Democracy Index; MoH, Ministry of Health; HTA, health technology assessment.
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of the following limitations. Even though participants were 
recruited from the organizations-members of the PFPA, 
which is an umbrella organization representing Cypriot 
patients at national and international level, we cannot claim 
that the sample was representative of the patient population 
in Cyprus. In addition, as patients with various chronic 
diseases were included into the sample, the sample size 
restricted us from exploring a potential influence of type of 
disease on PA participation. Future research should head 
towards this direction. Moreover, the HDI does not shed light 
on the barriers PAs experience, which hinder their effective 
involvement in procedures pertaining to health policy 
decision-making. For example, a growing body of research 
indicates that low health literacy; lack of training on advocacy 
and lobbying issues and poor knowledge of the health system, 
its operations and processes, all contribute to hampering PA 
participation in health policy decision-making.2,21,32,33 Since 
patient involvement in health policy decision-making is a 
necessary premise to improve the quality and performance of 
health systems and services as well as the health outcomes of 
the population, it is important to explore the barriers patients 
and patient organizations tackle throughout this process. In 
this way, we will be able to develop appropriate and adequate 
interventions and policies that would foster their participation 
in a sufficient and effective manner.
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